ClinicalTrials.Veeva

Menu

"Treatment Use of ECMO In Pregnancy or Peripartum Patient."

S

Sarah Thordsen

Status

Completed

Conditions

Peripartum Cardiomyopathy
Complication, Pregnancy
Cardiogenic Shock

Treatments

Device: Extracorporeal Membrane Oxygenation

Study type

Observational

Funder types

Other

Identifiers

NCT04144660
PRO00036221

Details and patient eligibility

About

The goal of this study is to describe the use of ECMO (Extracorporeal Membrane Oxygenation) in the pregnant or peripartum patient.

Enrollment

5 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Female
  2. Age 18 years or greater at the time of ECMO treatment.
  3. Pregnant or within 6 months post-partum at the time of ECMO cannulation

Exclusion criteria

  1. No history of pregnancy.
  2. No treatment with ECMO.

Trial design

5 participants in 1 patient group

Cardiogenic Shock Treated with ECMO
Description:
This cohort of participants required clinical intervention with ECMO for treatment of their index cardiogenic shock episode while pregnant or post delivery of their infant.
Treatment:
Device: Extracorporeal Membrane Oxygenation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems